Acasti pharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Acasti pharma Contact Number

Contact :: Acasti Pharma Inc. (ACST)

9 hours ago Acastipharma.com Show details

Contact . Acasti Completes Acquisition of Grace Therapeutics, Inc. Read Press Release. Acasti Pharma Inc. 3009 Boul. de la Concorde E. Suite 102 Laval, Québec, Canada H7E 2B5. 685 US Highway One, North Brunswick, NJ 08902. …

Category: Contact SupportShow more

Contacts :: Acasti Pharma Inc. (ACST)

Just Now Acastipharma.com Show details

Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company’s novel drug delivery technologies have the potential to improve the performance of currently…

Category: Contact SupportShow more

Acasti Pharma Inc. (ACST)

9 hours ago Acastipharma.com Show details

Contact . Acasti Completes Acquisition of Grace Therapeutics, Inc. Read Press Release. RESEARCH EXCELLENCE. Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company’s novel drug delivery technologies have the potential to improve the performance of

Category: Contact NumberShow more

Acasti Pharma Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Show details

450-686-4555Contact Email [email protected]acastipharma.com Phone Number 450-686-4555 Acasti Pharma is an emerging biopharmaceutical company dedicated to the research, development, and commercialization of innovative proprietary active pharmaceutical ingredients (API) for the management of cardiometabolic disorders, from prevention to treatment, through a novel

Founder: Pierre Lemieux
Location: Laval, Quebec
Founded: Jul 01, 2007

Category: Contact NumberShow more

Acasti Pharma Inc. Profile SEDAR

3 hours ago Sedar.com Show details

Acasti Pharma Inc. Mailing Address: 3009 boul. de la Concorde E. Suite 102 Laval, Québec H7E 2B5: Head Office Address: 3009 boul. de la Concorde E. Suite 102 Laval, Québec H7E 2B5: Contact Name: Brian D. Ford: Principal Regulator: Quebec: Business e-mail address: [email protected]: Short Form Prospectus Issuer: Yes: Telephone Number

Contact Name: Brian D. Ford
Principal Regulator: Quebec

Category: Contact NumberShow more

Acasti Pharma Inc. 2650 Maximilien Chagnon, Sherbrooke, QC

1 hours ago Yellowpages.ca Show details

Acasti Pharma Inc. - Sherbrooke - phone number, website & address - QC - . Find everything you need to know about Acasti Pharma Inc. on Yellowpages.ca Please …

Category: Contact NumberShow more

Acasti Pharma Company Profile Office Locations

Just Now Craft.co Show details

Acasti Pharma has 551 Twitter Followers. The number of followers has increased 0.8% month over month and increased 3.3% quarter over quarter. Acasti Pharma headquarters is located at 100-545 Promenade Du Centropolis, About …

Category: Contact NumberShow more

ACASTI PHARMA INC. :: France :: OpenCorporates

9 hours ago Opencorporates.com Show details

Free and open company data on France company ACASTI PHARMA INC. (company number 820310142), 545 PROMENADE DU CENTROPOLIS, LAVAL QUEBEC

Category: Contact NumberShow more

ACASTI PHARMA INC. :: Quebec (Canada) :: OpenCorporates

3 hours ago Opencorporates.com Show details

Free and open company data on Quebec (Canada) company ACASTI PHARMA INC. (company number 1160589793), 100-545 Promenade du Centropolis Laval Québec H7T0A3 Canada

Category: Contact NumberShow more

ACST Insider Trading Acasti Pharma, Inc.

7 hours ago Fintel.io Show details

Acasti Pharma Announces Annual Stock Option Grants. 11-15 sec.gov - EXHIBIT 99.1 Acasti Pharma Announces Annual Stock Option Grants LAVAL, Québec, Nov. 12, 2021 (GLOBE NEWSWIRE) - Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced the annual grant of stock options to its employees, executives

Category: Contact NumberShow more

Acasti Pharma, Inc. email format Acasti Pharma, Inc..com

5 hours ago Data.aeroleads.com Show details

Acasti Pharma, Inc. use these email formats. Get emails and phone number of Acasti Pharma, Inc. employees.

Category: Contact NumberShow more

ACST Institutional Ownership Acasti Pharma, Inc. Stock

8 hours ago Fintel.io Show details

Agreement and Plan of Merger dated as of May 7, 2021 among Acasti Pharma Inc., Acasti Pharma U.S., Inc. and Grace Therapeutics Inc. (incorporated by reference from Exhibit 2.1 of Acasti’s Current Report on Form 8-K filed with the SEC on May 7, 2021)

Category: Contact NumberShow more

ACASTI PHARMA :: South Africa :: OpenCorporates

4 hours ago Opencorporates.com Show details

Free and open company data on South Africa company ACASTI PHARMA (company number 2012-000779-07), 24 DELTA ROAD ELTON HILL SANDTON 2196

Category: Contact NumberShow more

Acasti Pharma Inc. (Form: 20F, Received: 06/29/2018 11:40:11)

7 hours ago Content.edgar-online.com Show details

843-18-0049Linda P. O’Keefe, Chief Financial Officer Acasti Pharma Inc. 545, Promenade du Centropolis, Suite 100 Laval, Québec H7T 0A3 Tel: 450-687-2262 Fax: 450-687-2272 (Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act.

Category: Contact NumberShow more

Acasti Stock Price ACST 1.39 0.06 (4.5113%)

Just Now Macroaxis.com Show details

Acasti Pharma is selling for under 1.39 as of the 14th of January 2022; that is 4.51 percent up since the beginning of the trading day. The stock's last reported lowest price was 1.3. Get the latest Acasti Pharma detailed stock quotes, stock trade data, stock price info, and performance analysis, including Acasti Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

Acasti Pharma Number of Employees 20142021 ACST

Just Now Macrotrends.net Show details

Acasti Pharma number of employees from 2014 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Compare ACST With Other Stocks. Select a timeframe to show chart data.

Category: Contact NumberShow more

Acasti Pharma Inc.

Just Now Acastipharma.com Show details

843-19-0041Jean-François Boily, Vice President, Finance, Acasti Pharma Inc. 545, Promenade du Centropolis, Suite 100 Laval, Québec H7T 0A3 Tel: 450-687-2262 Fax: 450-687-2272 (Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act.

Category: Contact NumberShow more

Acasti Pharma Inc. (via Public) / SC 13G

1 hours ago Publicnow.com Show details

Acasti Pharma Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 00430K105 (CUSIP Number) October 23, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1 (b) [X] Rule 13d-1 (c) [ ] Rule 13d-1 (d)

Category: Contact NumberShow more

Acasti Pharma Inc. (ACST) Company Profile & Facts Yahoo

4 hours ago Finance.yahoo.com Show details

See the company profile for Acasti Pharma Inc. (ACST) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their

Category: Contact NumberShow more

Acasti Pharma Inc.

Just Now Acastipharma.com Show details

125-17-2150Acasti Pharma Inc. 545, Promenade du Centropolis, Suite 100 Laval, Québec H7T 0A3 Tel: 450-687-2262 Fax: 450-687-2272 (Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act. Title of each class Name of each exchange on which registered

Category: Contact NumberShow more

Acasti Pharma Inc. LinkedIn

1 hours ago Linkedin.com Show details

Acasti Pharma Inc. 1,157 followers on LinkedIn. Acasti est un innovateur biopharmaceutique dont les activités sont axées sur la recherche, le développement et la commercialisation de

Category: Contact NumberShow more

EdgarFiling

8 hours ago Sec.gov Show details

450-686-4555Acasti Contact: Jan D’Alvise Chief Executive Officer Tel: 450-686-4555 Email: [email protected] www.acastipharma.com. Investor Contact: Crescendo Communications, LLC Tel: 212-671-1020 Email: [email protected]

Category: Contact NumberShow more

Cosavalt Trademark Acasti Pharma Inc. Bizapedia

9 hours ago Bizapedia.com Show details

Mark Identification: COSAVALT: Last Applicant/Owner: Acasti Pharma Inc. 545 Promenade Centropolis, Suite 100 Laval H7T0A : Serial Number: 88470279

Category: Contact NumberShow more

Neptune Technologies & Bioressources Inc. News Release

7 hours ago Sec.gov Show details

The Acasti Plan will allow the option holders to purchase a number of class A common shares of Acasti Pharma equal to the greatest of (i) 6,000,000, and (ii) 20% of the total number of issued and outstanding Class A, Class B and Class C shares of Acasti Pharma at any given moment.

Category: Tech SupportShow more

Acasti Pharma Announces Interim Data Meets All Primary

4 hours ago Acastipharma.com Show details

Acasti estimates the addressable market in the United States for GTX-104 to be approximately $300 million based on approximately 50,000 patients being affected by aSAH per year. About Acasti. Acasti is a specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases.

Category: Contact NumberShow more

Acasti Announces Filing and Mailing of Information Circular

7 hours ago Globenewswire.com Show details

Acasti Announces Filing and Mailing of Information Circular and Change in Record Date. LAVAL, Québec, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“ Acasti ” or the “ Company

Category: Contact NumberShow more

Form 8K Acasti Pharma Inc. For: Dec 02

7 hours ago Streetinsider.com Show details

Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104 we remain encouraged by the outlook for our business and look forward to reporting on a number

Category: Contact NumberShow more

Acasti Pharma Provides Update Following Acquisition of

Just Now Finance.yahoo.com Show details

LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and announced that the

Category: Contact NumberShow more

What is Acasti Pharma Valuation Today? ACST Macroaxis

4 hours ago Macroaxis.com Show details

Acasti Pharma Enterprise Value is comparatively stable at the moment as compared to the past year. Acasti Pharma reported Enterprise Value of 93.44 Million in 2021. Tangible Asset Value is likely to gain to about 77.5 M in 2022, whereas Free Cash Flow is likely to drop (14 M) in 2022. Acasti Pharma shows a prevailing Real Value of $2.4 per share.

Category: Contact NumberShow more

Premarket Mover: Acasti Pharma Inc (ACST) Down 10.65%

1 hours ago Investorsobserver.com Show details

Acasti Pharma Inc has a Long-Term Technical rank of 67. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 33% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, ACST ranks better than 87% of stocks. Important Dates for Investors in ACST:

Category: Contact NumberShow more

SEC

8 hours ago Sec.gov Show details

Montréal, Québec, Canada – July 15, 2016 - Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST – TSX-V:APO) of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of hypertriglyceridemia, announced that the nominees listed in its management proxy circular dated June 14, 2016 were elected as directors of Acasti at its Annual and …

Category: Contact NumberShow more

Acasti Pharma Announces Results for Third Quarter of

3 hours ago Finance.yahoo.com Show details

450-686-4555Acasti Contact:Jan D’AlviseChief Executive OfficerTel: 450-686-4555Email: [email protected]acastipharma.comwww.acastipharma.com Investor Contact:Crescendo Communications, LLCTel: 212-671-1020Email: ACST

Category: Contact NumberShow more

Acasti Pharma Inc. (ACST) Stock Price, News, Quote

6 hours ago Finance.yahoo.com Show details

Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference. LAVAL, Québec, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST

Category: Contact NumberShow more

UNITED STATES

Just Now Acastipharma.com Show details

843-21-0050ACASTI PHARMA INC. (Exact Name of Registrant as Specified in Charter) QUEBEC, CANADA 001-35776 98-1359336 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) 3009, boul. de la Concorde East Suite 102 Laval, Québec Canada H7E 2B5 (Address of Principal Executive Offices) (Zip Code) 450

Category: Contact NumberShow more

Acasti Pharma financials 2022 ACST Macroaxis

5 hours ago Macroaxis.com Show details

Acasti Pharma reported Average Equity of 29.12 Million in 2021. Enterprise Value is likely to gain to about 100.8 M in 2022, whereas Earnings before Tax are likely to drop (19.1 M) in 2022. We suggest to use analysis of Acasti Pharma fundamentals to see if markets are presently mispricing the company.

Category: Contact NumberShow more

Premarket Mover: Acasti Pharma Inc (ACST) Up 1.71%

8 hours ago Investorsobserver.com Show details

In the Biotechnology industry which is number 131 by this metric, ACST ranks better than 71% of stocks. Important Dates for Investors in ACST:-Acasti Pharma Inc is set to release earnings on 11/15/2021. During their last earnings release the company posted EPS of $-0.79. -We do not have a set dividend date for Acasti Pharma Inc at this time.

Category: Contact NumberShow more

Dawson v Acasti Pharma, Inc et al 1:21CV01039 Court

2 hours ago Unicourt.com Show details

Docket (#1) COMPLAINT filed with Jury Demand against Acasti Pharma U.S., Inc, Acasti Pharma, Inc., John Canan, Roderick Carter, Jan DAlvise, Grace Therapeutics, Inc., Donald Olds - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3659081.) - filed by Sean Dawson.

Category: Contact NumberShow more

Acasti Pharma Funding, Financials, Valuation & Investors

2 hours ago Crunchbase.com Show details

Acasti Pharma has raised a total of $54.9M in funding over 5 rounds. Their latest funding was raised on Oct 3, 2018 from a Post-IPO Equity round. Acasti Pharma is registered under the ticker NASDAQ:ACST . Acasti Pharma has acquired Grace Therapeutics on May 7, 2021. They acquired Grace Therapeutics for $64M.

Category: Contact NumberShow more

Acasti Pharma Net Worth 20142021 ACST MacroTrends

Just Now Macrotrends.net Show details

Interactive chart of historical net worth (market cap) for Acasti Pharma (ACST) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Acasti Pharma net worth as of January 14, 2022 is $0.04B .

Category: Contact NumberShow more

Acasti Pharma Stock Analysis 2022 ACST Macroaxis

9 hours ago Macroaxis.com Show details

Acasti Stock Analysis Notes About 12.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Acasti Pharma had 1:10 split on the 15th of October 2015. Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases.

Category: Contact NumberShow more

AVASTIN Prescribing Information Genentech

7 hours ago Gene.com Show details

Dosage and Administration (2.8) Warnings and Pre cautions (5.2) Warnings and Precautions (5.3, 5.9) 5/2020 12/2020 : 10/2020 . 5/2020 . 10/2020 . 5/2020

Category: Tech SupportShow more

Acasti Pharma Inc (ACST) is higher by 1.11% Friday In

Just Now Investorsobserver.com Show details

Acasti Pharma Inc has a Long-Term Technical rank of 55. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 45% of the market scoring higher. In the Biotechnology industry which is number 134 by this metric, ACST ranks better than 70% of stocks. Important Dates for Investors in ACST:

Category: Contact NumberShow more

Neptune Announces Royalty Prepayment Agreement With Acasti

2 hours ago Sec.gov Show details

Neptune Announces Royalty Prepayment Agreement With Acasti Pharma Inc. market value of each Share to be issued pursuant to the Prepayment Agreement upon the exercise of the Warrant and the number of Shares to be issued have been calculated in accordance with the pre-established formula set forth in the License Agreement. Neptune Contact

Category: Contact NumberShow more

ACST Stock Forecast, Price & News (Acasti Pharma)

6 hours ago Marketbeat.com Show details

Acasti Pharma's stock was trading at $3.0792 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ACST shares have decreased by 54.9% and is now trading at $1.39. View which stocks have been most impacted by COVID-19.

Category: Contact NumberShow more

www.sec.gov

1 hours ago Sec.gov Show details

843-21-0035Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Acasti Pharma Inc. (“Acasti” or the “Company”) today announced that, on May 11, 2021, the Company received notice from the Nasdaq Listing Qualifications Department (the “Staff”) indicating that, based upon the Company’s non-compliance with the $1.00 bid price

Category: Contact NumberShow more

EdgarFiling

8 hours ago Sec.gov Show details

After giving effect to the adjustments provided in the merger agreement based on each company’s capitalization and net cash balances, as described in more detail in the Circular, a total of 145,929,867 common shares of Acasti have been issued to Grace stockholders as consideration for the acquisition, bringing the total number of Acasti

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Where is acasti Pharma Inc based?

The company was incorporated in 2002 and is headquartered in Laval, Canada. Thinking about buying stock in SeaChange International, American Virtual Cloud Technologies, Quoin Pharmaceuticals, Acasti Pharma, or CohBar?

Are acasti Pharma insiders buying or selling stock?

In the past three months, Acasti Pharma insiders have not sold or bought any company stock. Only 12.75% of the stock of Acasti Pharma is held by institutions. Earnings for Acasti Pharma are expected to decrease in the coming year, from ($0.11) to ($0.27) per share.

What is acasti Pharma's PE (price/earnings) ratio?

The P/E ratio of Acasti Pharma is -2.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Acasti Pharma has a P/B Ratio of 0.59.

What is acecasti?

Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases.

Popular Brands

Amazon
Abbvie
Asml
Aia
Att
Apple
Amgen
Adobe
Aptar
Acc
Adidas
Aak